Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Maga

Showing results (131-140 of 214) with videos related to

Pageof 22
Sort By:
Antimicrobial Agents and Chemotherapy|October 28, 2005
High potency of indolyl aryl sulfone nonnucleoside inhibitors towards drug-resistant human immunodeficiency virus type 1 reverse transcriptase mutants is due to selective targeting of different mechanistic forms of the enzymeReynel Cancio, Romano Silvestri, Rino Ragno, et al.
Molecules (Basel, Switzerland)|December 23, 2022
Privileged Scaffold Decoration for the Identification of the First Trisubstituted Triazine with Anti-SARS-CoV-2 ActivitySilvia Cesarini, Ilaria Vicenti, Federica Poggialini, et al.
Antiviral Chemistry & Chemotherapy|October 18, 2006
Indolyl aryl sulphones as HIV-1 non-nucleoside reverse transcriptase inhibitors: synthesis, biological evaluation and binding mode studies of new derivatives at indole-2-carboxamideGabriella De Martino, Giuseppe La Regina, Rino Ragno, et al.
DNA Repair|December 26, 2006
Replication of 2-hydroxyadenine-containing DNA and recognition by human MutSalphaFlavia Barone, Scott D McCulloch, Peter Macpherson, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2010
Discovery of potent nucleotide-mimicking competitive inhibitors of hepatitis C virus NS3 helicaseSandra Gemma, Stefania Butini, Giuseppe Campiani, et al.
Journal of Medicinal Chemistry|June 25, 2005
Novel 1-[2-(diarylmethoxy)ethyl]-2-methyl-5-nitroimidazoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. A structure-activity relationship investigationGabriella De Martino, Giuseppe La Regina, Alessandra Di Pasquali, et al.
Journal of Medicinal Chemistry|September 7, 2007
Indolyl aryl sulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: role of two halogen atoms at the indole ring in developing new analogues with improved antiviral activityGiuseppe La Regina, Antonio Coluccia, Francesco Piscitelli, et al.
Journal of Medicinal Chemistry|March 4, 2011
Indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: new cyclic substituents at indole-2-carboxamideGiuseppe La Regina, Antonio Coluccia, Andrea Brancale, et al.
Journal of Medicinal Chemistry|April 29, 2005
Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RTMaria Letizia Barreca, Angela Rao, Laura De Luca, et al.
Bioorganic & Medicinal Chemistry|July 1, 2008
Novel N1-substituted 1,3-dihydro-2H-benzimidazol-2-ones as potent non-nucleoside reverse transcriptase inhibitorsAnna-Maria Monforte, Angela Rao, Patrizia Logoteta, et al.
Pageof 22

Showing results (131-140 of 214) with videos related to

Sort By:
Pageof 22
Antimicrobial Agents and Chemotherapy|October 28, 2005
High potency of indolyl aryl sulfone nonnucleoside inhibitors towards drug-resistant human immunodeficiency virus type 1 reverse transcriptase mutants is due to selective targeting of different mechanistic forms of the enzymeReynel Cancio, Romano Silvestri, Rino Ragno, et al.
Molecules (Basel, Switzerland)|December 23, 2022
Privileged Scaffold Decoration for the Identification of the First Trisubstituted Triazine with Anti-SARS-CoV-2 ActivitySilvia Cesarini, Ilaria Vicenti, Federica Poggialini, et al.
Antiviral Chemistry & Chemotherapy|October 18, 2006
Indolyl aryl sulphones as HIV-1 non-nucleoside reverse transcriptase inhibitors: synthesis, biological evaluation and binding mode studies of new derivatives at indole-2-carboxamideGabriella De Martino, Giuseppe La Regina, Rino Ragno, et al.
DNA Repair|December 26, 2006
Replication of 2-hydroxyadenine-containing DNA and recognition by human MutSalphaFlavia Barone, Scott D McCulloch, Peter Macpherson, et al.
Bioorganic & Medicinal Chemistry Letters|October 1, 2010
Discovery of potent nucleotide-mimicking competitive inhibitors of hepatitis C virus NS3 helicaseSandra Gemma, Stefania Butini, Giuseppe Campiani, et al.
Journal of Medicinal Chemistry|June 25, 2005
Novel 1-[2-(diarylmethoxy)ethyl]-2-methyl-5-nitroimidazoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. A structure-activity relationship investigationGabriella De Martino, Giuseppe La Regina, Alessandra Di Pasquali, et al.
Journal of Medicinal Chemistry|September 7, 2007
Indolyl aryl sulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: role of two halogen atoms at the indole ring in developing new analogues with improved antiviral activityGiuseppe La Regina, Antonio Coluccia, Francesco Piscitelli, et al.
Journal of Medicinal Chemistry|March 4, 2011
Indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: new cyclic substituents at indole-2-carboxamideGiuseppe La Regina, Antonio Coluccia, Andrea Brancale, et al.
Journal of Medicinal Chemistry|April 29, 2005
Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RTMaria Letizia Barreca, Angela Rao, Laura De Luca, et al.
Bioorganic & Medicinal Chemistry|July 1, 2008
Novel N1-substituted 1,3-dihydro-2H-benzimidazol-2-ones as potent non-nucleoside reverse transcriptase inhibitorsAnna-Maria Monforte, Angela Rao, Patrizia Logoteta, et al.
Pageof 22